Hartford Financial Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18
Closed -$667 387
2024
Q2
$667 Hold
18
﹤0.01% 378
2024
Q1
$756 Hold
18
﹤0.01% 376
2023
Q4
$714 Hold
18
﹤0.01% 385
2023
Q3
$496 Hold
18
﹤0.01% 386
2023
Q2
$611 Hold
18
﹤0.01% 365
2023
Q1
$648 Hold
18
﹤0.01% 373
2022
Q4
$802 Hold
18
﹤0.01% 366
2022
Q3
$1K Buy
+18
New +$552 ﹤0.01% 368
2022
Q2
Sell
-18
Closed -$1K 387
2022
Q1
$1K Hold
18
﹤0.01% 379
2021
Q4
$1K Hold
18
﹤0.01% 355
2021
Q3
$1K Hold
18
﹤0.01% 386
2021
Q2
$1K Buy
+18
New +$494 ﹤0.01% 370
2017
Q3
Sell
-18
Closed 389
2017
Q2
$0 Buy
+18
New +$796 ﹤0.01% 369
2017
Q1
Sell
-18
Closed -$1K 347
2016
Q4
$1K Hold
18
﹤0.01% 310
2016
Q3
$1K Hold
18
﹤0.01% 311
2016
Q2
$1K Hold
18
﹤0.01% 294
2016
Q1
$1K Hold
18
﹤0.01% 294
2015
Q4
$4K Hold
18
﹤0.01% 248
2015
Q3
$2K Hold
18
﹤0.01% 242
2015
Q2
$6K Buy
+18
New +$7.15K ﹤0.01% 231
2015
Q1
Sell
-18
Closed -$4K 131
2014
Q4
$4K Hold
18
﹤0.01% 231
2014
Q3
$3K Hold
18
﹤0.01% 265
2014
Q2
$4K Hold
18
﹤0.01% 258
2014
Q1
$4K Hold
18
﹤0.01% 237
2013
Q4
$6K Hold
18
﹤0.01% 215
2013
Q3
$9K Hold
18
0.01% 210
2013
Q2
$4K Buy
+18
New +$3.54K ﹤0.01% 241

Other funds holding CLDX